98892062 - PYRUKYND

Information

PYRUKYND

DM0000: The mark consists of four check mark designs joined at their bottoms, forming a stylized starburst shape with two purple triangles in the center; the check mark designs are colored turquoise, chartreuse, fuchsia and white, moving clockwise from the upper right of the design. The word "PYRUKYND" appears in stylized white lettering to the lower right of the starburst design, with the entire mark appearing upon a purple background.
GS0051: Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, sickle cell disease, pyruvate kinase deficiency (PKD), beta thalassemia and alpha thalassemia, genetically defined diseases affecting red blood cells, hereditary spherocytosis, hereditary elliptocytosis, dyserythropoiesis, hemolytic anemia, and other anemias
CC0000: The color(s) purple, fuchsia, chartreuse, turquoise and white is/are claimed as a feature of the mark.

12/9/2024 - a year ago
1 - NEW APPLICATION ENTERED Type: NWAP
12/9/2024 - a year ago
2 - APPLICATION FILING RECEIPT MAILED Type: MAFR
6/21/2025 - 6 months ago
4 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
6/22/2025 - 6 months ago
5 - ASSIGNED TO EXAMINER Type: DOCK
6/22/2025 - 6 months ago
6 - NON-FINAL ACTION WRITTEN Type: CNRT
6/22/2025 - 6 months ago
7 - NON-FINAL ACTION E-MAILED Type: GNRT
6/22/2025 - 6 months ago
8 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
6/21/2025 - 6 months ago
3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS